These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9449897)

  • 1. Calcium antagonists and cardiovascular events in patients with hypertension and diabetes.
    Alderman M; Madhavan S; Cohen H
    Lancet; 1998 Jan; 351(9097):216-7. PubMed ID: 9449897
    [No Abstract]   [Full Text] [Related]  

  • 2. CCBs vs ACE inhibitors in patients with diabetes.
    Zamorski MA
    J Fam Pract; 1998 Jul; 47(1):12-3. PubMed ID: 9673598
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcium antagonists and cardiovascular risk in diabetes. A review of the evidence.
    Mason RP; Mason PE
    Diabetes Care; 1999 Jul; 22(7):1206-8. PubMed ID: 10388991
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcium channel blockers. Consensus amid controversy.
    Kochar MS; Qurashi MI
    Postgrad Med; 1997 Dec; 102(6):127-8, 133-6. PubMed ID: 9406569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular events during antihypertensive treatment.
    Madren EM
    J Fam Pract; 1996 Dec; 43(6):534. PubMed ID: 8969693
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of hypertension with calcium antagonists. Heart and kidney protection for elderly type 2 diabetic patients].
    Keil TU
    MMW Fortschr Med; 2000 Mar; 142(11):18. PubMed ID: 10786084
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of antihypertensive treatment on endpoints in the diabetic patients randomized in the Systolic Hypertension in Europe (Syst-Eur) trial.
    Birkenhäger WH; Staessen JA; Gasowski J; de Leeuw PW
    J Nephrol; 2000; 13(3):232-7. PubMed ID: 10928302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antihypertensive drug therapy in diabetes mellitus].
    Ratzmann KP
    Z Arztl Fortbild (Jena); 1990; 84(21):1109-10. PubMed ID: 1980768
    [No Abstract]   [Full Text] [Related]  

  • 10. [Beta blockers and diuretics: therapeutic drugs of first choice in diabetes mellitus and hypertension].
    Sawicki PT
    Wien Klin Wochenschr; 1995; 107(21):629-39. PubMed ID: 8578749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The ALLHAT study: contributions, limitations and prospectives].
    Mancia G
    Ital Heart J Suppl; 2003 Feb; 4(2):77-84. PubMed ID: 12762256
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
    Tuomilehto J; Rastenyte D; Birkenhäger WH; Thijs L; Antikainen R; Bulpitt CJ; Fletcher AE; Forette F; Goldhaber A; Palatini P; Sarti C; Fagard R
    N Engl J Med; 1999 Mar; 340(9):677-84. PubMed ID: 10053176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug therapy of hypertension in diabetic patients.
    Stern N; Tuck M
    J Hum Hypertens; 1991 Aug; 5(4):295-305. PubMed ID: 1956028
    [No Abstract]   [Full Text] [Related]  

  • 14. [Calcium antagonists in treatment of hypertension].
    Landmark K; Reikvam A
    Tidsskr Nor Laegeforen; 2009 Dec; 129(23):2488-9. PubMed ID: 19997138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium antagonists should continue to be used for first-line treatment of hypertension.
    Epstein M
    Arch Intern Med; 1995 Nov; 155(20):2150-6. PubMed ID: 7487236
    [No Abstract]   [Full Text] [Related]  

  • 16. Calcium antagonists and cardiovascular risk in patients with hypertension and Type 2 diabetes mellitus: evidence from the PIUMA Study. Progetto Ipertensione Umbria Monitoraggio Ambulatoriale.
    Verdecchia P; Schillaci G; Reboldi G; Borgioni C; Ciucci A; Porcellati C
    Diabetes Nutr Metab; 1999 Aug; 12(4):292-9. PubMed ID: 10782756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term safety of antihypertensive therapy.
    Grossman E; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes and hypertension.
    Smolar EN
    Compr Ther; 1995 Oct; 21(10):597-601. PubMed ID: 8565430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. African-American ethnicity in epidemiological studies of calcium antagonists in relation to cancer.
    Zhu K; Daling JR; Pahor M
    Ethn Dis; 2002; 12(1):144-8. PubMed ID: 11913603
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET). More ammunition against surrogate end points.
    Califf RM; Granger CB
    Diabetes Care; 1998 Apr; 21(4):655-7. PubMed ID: 9571359
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.